XML 90 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Operating activities:    
Net income/ (loss) $ (24,437,209) $ (4,282,265)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation 1,760,072 686,059
Depreciation 4,636,161 3,041,783
Inventory provision 0 104,895
Amortization Expense 12,468,384 7,543,583
Intangibles and other amortization expense 253,600 0
Change in fair value of warrant liability (197,127) 97,022
Loss on extinguishment of debt 3,708,537 9,068,868
Gain on sale of assets (328,755) (350,356)
Gain on acquisition bargain purchase 0 (42,335,876)
Deferred tax liability/(asset) 0 (1,085,257)
Changes in assets and liabilities:    
Accounts receivable (1,486,830) 3,113,643
Inventory 210,837 (740,242)
Prepaid expenses 13,535 148,166
Other current assets and other assets (693,472) 475,965
Accounts payable (5,411,595) 799,620
Accrued interest expense and fees, net of payments 7,007,176 4,007,260
Other liabilities 813,561 2,775,405
Net cash used in operating activities (1,683,125) (16,931,727)
Investing activities:    
Capital expenditures (1,275,855) (1,368,395)
Proceeds from the sale of assets 1,499,852 1,404,166
Acquisition of Cilion 0 (16,500,000)
Net cash provided/(used in) investing activities 223,997 (16,464,229)
Financing activities:    
Proceeds from borrowing under secured debt facilities 4,800,000 39,840,000
Repayments of borrowing under secured debt facilities (400,000) (9,962,259)
Proceeds from borrowings under unsecured and subdebt term notes and working capital lines of credit 5,740,856 7,325,325
Repayments of borrowings under unsecured and subdebt notes and working capital facility (4,973,675) (3,868,050)
Issuance of Common stock through Equity offering and Warrant exercises 1,082,735 1,433
Net cash provided by financing activities 6,249,916 33,336,449
Effect of exchange rate changes on cash and cash equivalents (155,571) 100,644
Net cash and cash equivalents increase for period 4,635,217 41,137
Cash and cash equivalents at beginning of period 290,603 249,466
Cash and cash equivalents at end of period 4,925,820 290,603
Supplemental disclosures of cash flow information, cash paid:    
Interest payments 4,522,097 2,084,751
Income taxes expense (5,765) 4,000
Supplemental disclosures of cash flow information, non-cash transactions:    
Issuance of warrants to subordinated debt holders 1,127,120 0
Payment of principal, fees and interest by issuance of stock 3,616,284 11,885,579
Issuance of shares to related party for repayment of line of credit 821,946 4,107,141
Issuance of warrants to non-employees to secure procurement and working capital agreement 335,617 0
Other asset transferred to related party 170,000 0
Warrant liability transferred to equity upon exercise 1,006,648 0
Issuance of shares for acquisition 0 12,511,200
Beneficial conversion discount on related party debt 0 884,851
Seller note payable at fair value $ 0 $ 3,584,371